alexa Cyclophosphamide Pulse Therapy In Pemphigus | 61871
ISSN: 2155-9554

Journal of Clinical & Experimental Dermatology Research
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

11th Global Dermatologists Congress

Shahid Javaid Akhtar
Punjab Medical College, Pakistan
ScientificTracks Abstracts: J Clin Exp Dermatol Res
DOI: 10.4172/2155-9554.C1.044
Abstract
Introduction: Pemphigus vulgaris is a potentially fatal disease which has high death rate of up to 100% before the advent of systemic corticosteroids. But now the major cause of mortality is the side effects of these and steroid-sparing agents. Dr. J S Pasricha used Dexamethasone Cyclophosphamide Pulse therapy in 1989 for the first time to overcome this issue. But it has got its own technical flaws. We made some logical modifications in this regime to minimize the side effects and maximum the efficacy of pulse therapy. Objective: To see the efficacy of cyclophosphamide pulse therapy in pemphigus vulgaris. Patients & Methods: 20 new patients of pemphigus vulgaris attending the OPDs of hospitals (Allied and DHQ) attached with Punjab Medical College, Faisalabad were enrolled. After getting baseline investigations, IV cyclophosphamide (0.75-1 g/m2) was given after every 3-4 weeks. Oral Ondansetron hydrochloride 8 mg on day 1-5 and 8 mg of IV Dexamethasone on day 1-3 to prevent chemotherapy induced nausea and vomiting was also administered. Patients were advised to drink plenty of water and micturate frequently on day one to safeguard against potential cystitis. Oral prednisolone was also given in the standard dosage of 1 mg/kg, however, it was tapered earlier but gradually first to single morning dose and then to alternate day therapy once the clinical remission was achieved. These were ultimately completely withdrawn but cyclophosphamide pulses were continued 6-12 months after complete clearance of skin lesions. Results: 15 patients completed the therapeutic trial according to the original protocol; 8 of these are now off all therapy and are in clinical remission for more than two years. Three patients are only receiving their monthly cyclophosphamide pulses and are also symptom free; rest of the enrolled (n=4) are taking 15 mg of prednisolone in addition of cyclophosphamide pulses but are free of skin lesions. Apart from transient nausea and body aches, none of the patient experienced any major side effect. Conclusion: Cyclophosphamide pulse therapy for pemphigus vulgaris seems to be efficacious and may provide cure in this potentially fatal autoimmune disease though a large number of patients and longer follow up is required before making a final conclusion.
Biography

Shahid Javaid Akhtar is a talented, skilled and renowned Doctor with more than 20 years of experience in dermatology. He is a Professor of Dermatology at Punjab Medical College, Pakistan.

Email: [email protected]

image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version